Back to Search
Start Over
Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.
- Source :
- Journal of Rheumatology; May2024, Vol. 51 Issue 5, p488-494, 7p
- Publication Year :
- 2024
-
Abstract
- Objective. Systemic lupus erythematosus (SLE) flares are associated with increased damage and decreased health-related quality of life. We hypothesized that there is discordance between physicians' and patients' views of SLE flare. In this study, we aimed to explore patient and physician descriptions of SLE flares. Methods. We conducted a qualitative descriptive study using in-depth interviews with a purposeful sample of patients with SLE (who met 1997 American College of Rheumatology or Systemic Lupus International Collaborating Clinics criteria) and practicing rheumatologists. Interviews were audio-recorded, transcribed, and analyzed using applied thematic analysis. Methods. We conducted a qualitative descriptive study using in-depth interviews with a purposeful sample of patients with SLE (who met 1997 American College of Rheumatology or Systemic Lupus International Collaborating Clinics criteria) and practicing rheumatologists. Interviews were audio-recorded, transcribed, and analyzed using applied thematic analysis. Conclusion. Patients and physicians described flare differently. Participants with SLE perceived flares as several days of fatigue, pain, and skin issues. Providers defined flares as periods of increased clinical SLE activity. Our findings suggest the current definition of flare may be insufficient to integrate both perceptions. Further study is needed to understand the pathophysiology of patient flares and the best way to incorporate patients' perspectives into clinical assessments. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 0315162X
- Volume :
- 51
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Journal of Rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 177096198
- Full Text :
- https://doi.org/10.3899/jrheum.2023-0721